{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:19:09Z","timestamp":1701087549427},"reference-count":20,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2014.00060","type":"journal-article","created":{"date-parts":[[2014,5,26]],"date-time":"2014-05-26T14:00:21Z","timestamp":1401112821000},"source":"Crossref","is-referenced-by-count":4,"title":["Can Antipsychotic Agents be Considered as Real Antimanic Treatments?"],"prefix":"10.3389","volume":"5","author":[{"given":"Michel","family":"Bourin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphar.2013.00004","article-title":"How assess drugs in the treatment of acute bipolar mania?","volume":"4","author":"Bourin","year":"2013","journal-title":"Front Pharmacol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome implication for a dopamine hypothesis of bipolar disorder","volume":"434","author":"Berk","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"B3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.yic.0000132775.98340.b1","article-title":"Antipsychotic drugs in mania: factors predicting use of antipsychotic medication following inpatient treatment of mania","volume":"19","author":"Samellas","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition \u00e2\u20ac\u201c recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"9712","key":"B5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (balance): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 4","key":"B6","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-0327(00)00162-2","article-title":"A meta-analysis of the use of typical antipsychotic agents in bipolar disorder","volume":"65","author":"Tohen","year":"2001","journal-title":"J Affect Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/hup.561","article-title":"Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs","volume":"19","author":"Bourin","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1358\/dnp.1998.11.10.863663","article-title":"Pharmacology of new antipsychotic drugs: are they stabilizers of schizophrenic psychosis?","volume":"11","author":"Jolliet","year":"1998","journal-title":"Drug News Perspect"},{"issue":"Suppl 426","key":"B11","first-page":"1","article-title":"Atypical mood stabilizers: a \u00e2\u20ac\u0153typical\u00e2\u20ac\u009d role for atypical antipsychotics","volume":"111","author":"Malhi","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hup.657","article-title":"Treatment of acute mania from clinical trials to recommendations for clinical practice","volume":"20","author":"Bourin","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.euroneuro.2009.04.003","article-title":"Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, NICE","volume":"19","author":"Goodwin","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-642-25761-2_8","article-title":"Antipsychotics in the treatment of bipolar disorder","volume":"212","author":"Singh","year":"2012","journal-title":"Handb Exp Pharmacol"},{"issue":"9799","key":"B15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jad.2010.11.009","article-title":"Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania \u00e2\u20ac\u201c a systematic review and meta-analysis","volume":"13","author":"Tarr","year":"2011","journal-title":"J Affect Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania. Double-blind randomised comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br J Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"CD005000","DOI":"10.1002\/14651858.CD005000.pub2","article-title":"Aripiprazole alone or in combination for acute mania","volume":"12","author":"Brown","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00023210-200418060-00008","article-title":"Aripiprazole, a viewpoint","volume":"18","author":"Bourin","year":"2004","journal-title":"CNS Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2147\/NDT.S40066","article-title":"When to start aripiprazole therapy in patients with bipolar mania","volume":"10","author":"Sayyaparaju","year":"2014","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T20:19:30Z","timestamp":1424290770000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2014.00060\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2014.00060","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,26]]}}}